Lithuania joins clinical trials for Japanese Covid-19 drug
Following the completion of all the necessary procedures,
Lithuania is officially joining clinical trials of the drug Avigan developed by Japanese scientists, Veryga told reporters.
The trial will involve up to 100 patients in Lithuania, he said.
According to the Health Ministry,
the new drug is expected to help fight the coronavirus infection and stop it from spreading.
Foreign Minister Linas Linkevičius said that
the Lithuanian embassy in Japan had held intensive diplomatic talks since late March, adding that all diplomatic procedures had already been completed.
LRT